Andrea Popelová Selected Research

Prolactin-Releasing Hormone (Prolactin Releasing Hormone)

1/2021	Palmitoylated Prolactin-releasing Peptide Reduced Aβ Plaques and Microgliosis in the Cerebellum: APP/PS1 Mice Study.
1/2021	Lipidized Prolactin-Releasing Peptide as a New Potential Tool to Treat Obesity and Type 2 Diabetes Mellitus: Preclinical Studies in Rodent Models.
9/2020	Cellular Signaling and Anti-Apoptotic Effects of Prolactin-Releasing Peptide and Its Analog on SH-SY5Y Cells.
1/2018	Novel Lipidized Analog of Prolactin-Releasing Peptide Improves Memory Impairment and Attenuates Hyperphosphorylation of Tau Protein in a Mouse Model of Tauopathy.
1/2017	Impact of novel palmitoylated prolactin-releasing peptide analogs on metabolic changes in mice with diet-induced obesity.
1/2016	Prolactin-releasing peptide: a new tool for obesity treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrea Popelová Research Topics

Disease

6	Obesity 06/2021 - 01/2016
5	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 01/2018
4	Type 2 Diabetes Mellitus (MODY) 01/2021 - 01/2017
2	Neuroinflammatory Diseases 06/2021 - 01/2021
2	Gliosis 01/2021 - 01/2019
2	Body Weight (Weight, Body) 01/2021 - 01/2016
2	Alzheimer Disease (Alzheimer's Disease) 08/2019 - 01/2019
1	Insulin Resistance 01/2021
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021
1	Glucose Intolerance 01/2021
1	Nervous System Diseases (Neurological Disorders) 09/2020
1	Neuroblastoma 09/2020
1	Amyloid Plaque 01/2018
1	Tauopathies 01/2018
1	Decapitation 01/2018

Drug/Important Bio-Agent (IBA)

6	Prolactin-Releasing Hormone (Prolactin Releasing Hormone)IBA 01/2021 - 01/2016
4	palm11-PrRP31IBA 01/2021 - 01/2018
4	Peptides (Polypeptides)IBA 01/2021 - 01/2016
3	tau Proteins (tau Protein)IBA 06/2021 - 01/2018
2	Amyloid (Amyloid Fibrils)IBA 01/2021 - 08/2019
2	LeptinIBA 01/2021 - 01/2017
2	Pharmaceutical PreparationsIBA 01/2021 - 09/2020
2	NeuropeptidesIBA 01/2021 - 01/2016
2	Liraglutide FDA Link 01/2019 - 01/2018
1	Anti-Obesity Agents (Antiobesity Drugs)IBA 01/2021
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2021
1	LipidsIBA 08/2019
1	1,5-diaminonaphthaleneIBA 08/2019
1	AntibodiesIBA 01/2018
1	Triglycerides (Triacylglycerol)IBA 01/2017
1	CholesterolIBA 01/2017
1	Niacinamide (Nicotinamide)FDA LinkGeneric 01/2017
1	Insulin (Novolin)FDA Link 01/2017
1	Nonesterified Fatty Acids (NEFA)IBA 01/2017
1	prolactin-releasing peptide receptorIBA 01/2016
1	Glucose (Dextrose)FDA LinkGeneric 01/2016

Therapy/Procedure

2	Therapeutics 01/2021 - 01/2016
1	Lasers (Laser) 08/2019